Horse Deworming: Rotational vs Targeted Programme

By Sarah Bennett, Certified Animal Nutritionist

For decades, the standard advice to horse owners was simple: rotate through different anthelmintic drugs on a fixed calendar schedule and deworm every horse on the property at the same time. It was an approach born from practicality, but the science has moved on decisively. Today, the evidence strongly supports a shift to targeted selective treatment — a smarter, evidence-based approach that deworms the right horses at the right time with the right drug, and preserves the effectiveness of the small number of anthelmintic drugs we have available.

Understanding Equine Parasites

Before discussing treatment strategy, it helps to understand what you are treating. Horses are host to a wide range of internal parasites, and the relative importance of different species has changed significantly over the past thirty years.

Large strongyles (Strongylus vulgaris and related species) were historically the most dangerous equine parasite. Their larvae migrate through the mesenteric arteries, causing potentially fatal arteritis and colic. Thanks largely to the widespread use of ivermectin from the 1980s onwards, large strongyle infections are now rare in well-managed horses in many countries — though they should never be ignored entirely.

Small strongyles (cyathostomins) are now the dominant internal parasite threat to horses. Over 50 species exist, and they are resilient: larvae can encyst in the gut wall for months to years, emerging en masse in late winter or early spring to cause a syndrome called larval cyathostominosis — severe protein-losing enteropathy with watery diarrhoea, rapid weight loss, and ventral oedema. This condition carries a significant mortality rate even with intensive treatment. Crucially, cyathostomins have developed resistance to benzimidazoles (fenbendazole, oxibendazole) and pyrantel on many properties, making these drugs ineffective as sole agents in many situations.

Bot flies (Gasterophilus species) lay yellow eggs on the horse's coat during summer and autumn. The horse licks the eggs, which hatch and develop as larvae in the stomach through winter before passing out in spring. Bot infestations are rarely life-threatening in small numbers, but heavy burdens can cause gastric irritation and ulceration. Treatment is typically given in late autumn or early winter after the first frost has killed adult bot flies.

Tapeworms (Anoplocephala perfoliata) are increasingly recognised as a significant cause of spasmodic colic and, in heavy infections, ileocaecal intussusception. Standard egg counts do not detect tapeworms reliably; diagnosis requires a saliva-based ELISA test (EquiSal Tapeworm test) or blood serology. Treatment with praziquantel or a double dose of pyrantel is effective.

Why Rotational Deworming Is Now Outdated

The rotational approach — cycling through drug classes every 6–8 weeks regardless of each horse's actual worm burden — was designed for an era when large strongyles were the dominant threat and all available drugs were broadly effective. It has two critical flaws in the modern context.

First, it treats all horses equally regardless of their actual parasite burden. Research consistently shows that within any group of horses, roughly 20% of individuals shed 80% of the eggs present on a property (the so-called 20/80 rule). These "high shedders" are the horses that truly need regular treatment. The majority of horses are low or moderate shedders and may need treatment only once or twice a year. Treating low shedders as frequently as high shedders provides no additional parasite control benefit but dramatically increases selection pressure for drug resistance.

Second, frequent anthelmintic use accelerates the development of resistance in worm populations. Resistance to benzimidazoles is now widespread globally. Pyrantel resistance is also reported with increasing frequency. If ivermectin and moxidectin — our most effective remaining drugs — develop widespread resistance, the consequences for equine welfare and the management of serious parasitic disease will be severe.

Fecal Egg Counts: The Cornerstone of Targeted Treatment

The foundation of a targeted selective treatment programme is the fecal egg count (FEC). A small fresh manure sample is examined under a microscope (using a modified McMaster or Mini-FLOTAC technique) to count the number of strongyle eggs per gram. Results are categorised as:

• Low shedder: fewer than 200 eggs per gram (EPG)
• Moderate shedder: 200–500 EPG
• High shedder: over 500 EPG

Treatment thresholds vary between equine parasitologists and by country, but a common approach is to treat horses showing over 200–500 EPG, horses showing clinical signs, and young horses under five years (who have not yet developed strong immune regulation of worm populations). Low shedders may not need treatment more than once or twice a year.

A fecal egg count reduction test (FECRT) — performed by counting eggs before treatment and again 14 days after — allows you to assess whether the drug used is still effective on your property. A reduction below 95% for ivermectin or moxidectin, or below 90% for other drugs, suggests developing resistance and should be discussed with your equine vet immediately.

Anthelmintic Drugs: What You Need to Know

Ivermectin is a macrocyclic lactone with broad-spectrum activity against adult and larval strongyles, bots, and many other parasites. It remains highly effective against large strongyles and adult cyathostomins on most properties. It does not have reliable activity against encysted small strongyle larvae.

Moxidectin is a second-generation macrocyclic lactone with activity against encysted cyathostomin larvae as well as adults — making it the drug of choice when larval cyathostominosis is a concern. It has a longer residual activity than ivermectin. Because moxidectin is one of our most potent tools, it should be used strategically rather than routinely.

Praziquantel is the treatment of choice for tapeworms and is typically combined with ivermectin or moxidectin in combination products for convenience. It is generally given once or twice a year based on tapeworm test results or local risk assessment.

Fenbendazole and oxibendazole (benzimidazoles) still have a role in certain situations — for example, a five-day course of fenbendazole at larvicidal doses for encysted larvae — but should not be used without FEC evidence of efficacy on your property due to widespread resistance.

When to Deworm: A Practical Calendar

A targeted programme is built around FECs timed to the seasons. A typical schedule for an adult horse in a temperate climate might look like this: FEC in spring (March/April) to identify high shedders before peak transmission season; FEC again in autumn (September/October) before housing; a strategic treatment for tapeworms and bots in late autumn after the first frost. Horses identified as high shedders receive additional treatments when FEC results cross the threshold. Low shedders may require only the autumn treatment.

Younger horses (under five years), horses under significant stress, and immunocompromised individuals need more conservative, more frequent monitoring. New horses arriving on a property should be quarantined and treated with moxidectin before introduction to reduce the risk of importing resistant worms.

Pasture Management as a Complementary Tool

Drug treatment alone cannot solve a high worm burden if pasture management is poor. Strongyle eggs passed in manure develop into infective larvae on pasture within days in warm, moist conditions. Harrowing pastures in hot, dry weather to desiccate larvae, rotating pastures, removing manure regularly, and avoiding overstocking all significantly reduce the infective larval challenge on your land — reducing the need for frequent treatment.

References

1. Nielsen MK, Reinemeyer CR, Donecker JM, et al. "Anthelmintic resistance in equine parasites — current evidence and recommendations for prevention." International Journal for Parasitology: Drugs and Drug Resistance. 2014;4(3):187–196. PubMed PMID: 25516831
2. Traversa D, von Samson-Himmelstjerna G, Demeler J, et al. "Anthelmintic resistance in equid gastrointestinal parasites in central and northern Italy and Germany." Parasites & Vectors. 2009;2(Suppl 2):S2. PubMed PMID: 19891757

Author: Sarah Bennett, Certified Animal Nutritionist